Erratum: A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of b-Catenin (American Journal of Respiratory and Critical Care Medicine (2016) 194 (185–197) DOI: 10.1164/rccm.201505-0999OC);A chronic obstructive pulmonary disease susceptibility gene, FAM13A, regulates protein stability of β-catenin

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 2, 2016, Pages 185-197

  Jiang, Zhiqiang ^a   Lao, Taotao ^a   Qiu, Weiliang ^a   Polverino, Francesca ^b,c   Gupta, Kushagra ^b   Guo, Feng ^a   Mancini, John D ^a   Naing, Zun Zar Chi ^a   Cho, Michael H ^a,b   Castaldi, Peter J ^a,d   Sun, Yang ^b   Yu, Jane ^b   Laucho Contreras, Maria E ^b   Kobzik, Lester ^e   Raby, Benjamin A ^a,b   Choi, Augustine M K ^f   Perrella, Mark A ^a,b   Owen, Caroline A ^b,c   Silverman, Edwin K ^a,b   Zhou, Xiaobo ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Weill Cornell Medicine   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d Division of General Internal Medicine   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell proliferation; Emphysema; FAM13A; Protein stability; catenin

Indexed keywords

AXIN; AXIN 1; BETA CATENIN; CIGARETTE SMOKE; FAM13A PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; KI 67 ANTIGEN; MUCIN 5AC; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

AIRWAY EPITHELIAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ELASTASE-INDUCED EMPHYSEMA; EXON; FEMALE; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LEUKOCYTE COUNT; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TYPE 2 EPITHELIAL CELL; WESTERN BLOTTING; WILD TYPE; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN STABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION;

EID: 84988941641     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.v202erratum8     Document Type: Erratum

References (71)

1. Miniño AM. Death in the United States, 2011. NCHS Data Brief 2013; 115:1-8.
2. Miniño AM, Kochanek KD. Division of Vital Statistics. Deaths: preliminary data for 2008. U.S. Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. National Vital Statistics Reports 2010:1-72.
3. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205.
4. Fletcher C, Peto R, Tinker C, Speizer FE. Factors related to the development of airflow obstruction. In: The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press; 1976. pp. 70-105.
5. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001;164:1419-1424.
6. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157: 1770-1778.
7. Gibson G. Hints of hidden heritability in GWAS. Nat Genet 2010;42: 558-560.
8. Manolio TA. Genome-wide association studies and assessment of the risk of disease. N Engl J Med 2010;363:166-176.
9. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362-9367.
10. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-197.
11. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010;42:200-202.
12. Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, et al.; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2014;2:214-225.
13. Baarsma HA, Spanjer AI, Haitsma G, Engelbertink LH, Meurs H, Jonker MR, Timens W, Postma DS, Kerstjens HA, Gosens R. Activation of WNT/b-catenin signaling in pulmonary fibroblasts by TGF-b1 is increased in chronic obstructive pulmonary disease. PLoS One 2011;6:e25450.
14. Vasioukhin V, Fuchs E. Actin dynamics and cell-cell adhesion in epithelia. Curr Opin Cell Biol 2001;13:76-84.
15. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850.
16. Reynolds SD, Zemke AC, Giangreco A, Brockway BL, Teisanu RM, Drake JA, Mariani T, Di PY, Taketo MM, Stripp BR. Conditional stabilization of beta-catenin expands the pool of lung stem cells. Stem Cells 2008;26:1337-1346.
17. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005;123:903-915.
18. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, Yang J, DeMayo FJ, Whitsett JA, Parmacek MS, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet 2008;40:862-870.
19. Zhang L, Gallup M, Zlock L, Basbaum C, Finkbeiner WE, McNamara NA. Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120-catenin with the cytoplasmic tail of MUC1. J Pathol 2013;229:74-86.
20. Sun Z, Gong X, Zhu H, Wang C, Xu X, Cui D, Qian W, Han X. Inhibition of Wnt/b-catenin signaling promotes engraftment of mesenchymal stem cells to repair lung injury. J Cell Physiol 2014;229:213-224.
21. Kneidinger N, Yildirim AO, Callegari J, Takenaka S, Stein MM, Dumitrascu R, Bohla A, Bracke KR, Morty RE, Brusselle GG, et al. Activation of the WNT/b-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med 2011;183:723-733.
22. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010;298:L715-L731.
23. Jiang Z, Polverino F, Lao T, Qiu W, Gupta K, Mancini J, Cho M, Castaldi P, Guo F, Laucho-Contreras M, et al. The chronic obstructive pulmonary disease susceptibility gene Fam13a negatively regulates the b-catenin/Wnt pathway. Presented at Federation of American Societies for Experimental Biology Science Research Conferences for Lung Epithelium in Health & Disease. July 27-August 1, 2014, Saxtons River, VT.
24. Zhou X, Baron RM, Hardin M, Cho MH, Zielinski J, Hawrylkiewicz I, Sliwinski P, Hersh CP, Mancini JD, Lu K, et al. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. Hum Mol Genet 2012;21:1325-1335.
25. Testa G, Schaft J, van der Hoeven F, Glaser S, Anastassiadis K, Zhang Y, Hermann T, Stremmel W, Stewart AF. A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis 2004;38:151-158.
26. Moghadaszadeh B, Rider BE, Lawlor MW, Childers MK, Grange RW, Gupta K, Boukedes SS, Owen CA, Beggs AH. Selenoprotein N deficiency in mice is associated with abnormal lung development. FASEB J 2013;27:1585-1599.
27. Laucho-Contreras ME, Taylor KL, Mahadeva R, Boukedes SS, Owen CA. Automated measurement of pulmonary emphysema and small airway remodeling in cigarette smoke-exposed mice. J Vis Exp 2015; 95:52236.
28. Wang Y, Zhou X, Zhu H, Liu S, Zhou C, Zhang G, Xue L, Lu N, Quan L, Bai J, et al. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 2005;24: 6637-6645.
29. Rock J, Kö nigshoff M. Endogenous lung regeneration: potential and limitations. Am J Respir Crit Care Med 2012;186:1213-1219.
30. Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014;507: 190-194.
31. Lao T, Glass K, Qiu W, Polverino F, Gupta K, Morrow J, Mancini JD, Vuong L, Perrella MA, Hersh CP, et al. Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring. Genome Med 2015;7:12.
32. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004;170:974-980.
33. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 2003;36:95-109.
34. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006;7:675-681.
35. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-1356.
36. Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med 2012;106:319-328.
37. Owen CA. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2: 373-385. [Discussion 394-375.]
38. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008;40:1334-1347.
39. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:253-268.
40. Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem WG, Deslee G, Moore CH, Jacobs ME, et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2011;183:876-884.
41. Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol Cell 2008;31:873-885.
42. Zou W, Zou Y, Zhao Z, Li B, Ran P. Nicotine-induced epithelial-mesenchymal transition via Wnt/b-catenin signaling in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013;304: L199-L209.
43. Lee JM, Yang J, Newell P, Singh S, Parwani A, Friedman SL, Nejak-Bowen KN, Monga SP. b-Catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation. Cancer Lett 2014;343:90-97.
44. Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci USA 1999;96:6273-6278.
45. Zeng J, Liu D, Qiu Z, Huang Y, Chen B, Wang L, Xu H, Huang N, Liu L, Li W. GSK3b overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells. PLoS One 2014;9:e91231.
46. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 1999;285:1923-1926.
47. DasGupta R, Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999;126:4557-4568.
48. Beyer C, Reichert H, Akan H, Mallano T, Schramm A, Dees C, Palumbo-Zerr K, Lin NY, Distler A, Gelse K, et al. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Ann Rheum Dis 2013;72:1255-1258.
49. Leow PC, Tian Q, Ong ZY, Yang Z, Ee PL. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/b-catenin antagonists against human osteosarcoma cells. Invest New Drugs 2010;28:766-782.
50. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med 1998;158:555-564.
51. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295: L1-L15.
52. Wright JL, Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med 2010;4: 723-734.
53. Wang R, Ahmed J, Wang G, Hassan I, Strulovici-Barel Y, Hackett NR, Crystal RG. Down-regulation of the canonical Wnt b-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD. PLoS One 2011;6:e14793.
54. Kim TH, Kim SH, Seo JY, Chung H, Kwak HJ, Lee SK, Yoon HJ, Shin DH, Park SS, Sohn JW. Blockade of the Wnt/b-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med 2011;223:45-54.
55. Li Y, Shi J, Yang J, Ma Y, Cheng L, Zeng J, Hao X, Ma C, Wang Y, Liu X. A Wnt/b-catenin negative feedback loop represses TLR-triggered inflammatory responses in alveolar epithelial cells. Mol Immunol 2014;59:128-135.
56. Tanjore H, Degryse AL, Crossno PF, Xu XC, McConaha ME, Jones BR, Polosukhin VV, Bryant AJ, Cheng DS, Newcomb DC, et al. b-catenin in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin. Am J Respir Crit Care Med 2013;187:630-639.
57. Aggarwal NR, Chau E, Garibaldi BT, Mock JR, Sussan T, Rao K, Rao K, Menon AG, D'Alessio FR, Damarla M, et al. Aquaporin 5 regulates cigarette smoke induced emphysema by modulating barrier and immune properties of the epithelium. Tissue Barriers 2013;1:e25248.
58. Lemjabbar H, Li D, Gallup M, Sidhu S, Drori E, Basbaum C. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem 2003;278:26202-26207.
59. Muyal JP, Kotnala S, Bhardwaj H, Tyagi A. Effect of recombinant human keratinocyte growth factor in inducing Ras-Raf-Erk pathway-mediated cell proliferation in emphysematous mice lung. Inhal Toxicol 2014;26:761-771.
60. Fang X, Li K, Tao X, Chen C, Wang X, Wang L, Wang DC, Zhang Y, Bai C, Wang X. Effects of phosphoinositide 3-kinase on protease-induced acute and chronic lung inflammation, remodeling, and emphysema in rats. Chest 2013;143:1025-1035.
61. Arnold HK, Sears RC. A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev 2008;27:147-158.
62. Li X, Yost HJ, Virshup DM, Seeling JM. Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus. EMBO J 2001;20:4122-4131.
63. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 1999;283:2089-2091.
64. Geraghty P, Hardigan AA, Wallace AM, Mirochnitchenko O, Thankachen J, Arellanos L, Thompson V, D'Armiento JM, Foronjy RF. The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction. Am J Respir Cell Mol Biol 2013;49:721-730.
65. Jin Z, Chung JW, Mei W, Strack S, He C, Lau GW, Yang J. Regulation of nuclear-cytoplasmic shuttling and function of family with sequence similarity 13, member A (Fam13a), by B56-containing PP2As and Akt. Mol Biol Cell 2015;26:1160-1173.
66. Ding VW, Chen RH, McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem 2000;275:32475-32481.
67. Sutton LP, Rushlow WJ. The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3. Int J Neuropsychopharmacol 2012;15:965-979.
68. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T, et al. Wnt signaling through inhibition of b-catenin degradation in an intact Axin1 complex. Cell 2012;149:1245-1256.
69. Morrisey EE, Cardoso WV, Lane RH, Rabinovitch M, Abman SH, Ai X, Albertine KH, Bland RD, Chapman HA, Checkley W, et al. Molecular determinants of lung development. Ann Am Thorac Soc 2013;10: S12-S16.
70. Lamontagne M, Couture C, Postma DS, Timens W, Sin DD, Paré PD, Hogg JC, Nickle D, Laviolette M, Bossé Y. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One 2013;8:e70220.
71. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013;45:613-620.